Denaro N - Search Results

1

A narrative review of the principal glucocorticoids employed in cancer.

Denaro N, Garrone O, Morelli A, Pellegrino B, Merlano MC, Vacca D, Pearce J, Farci D, Musolino A, Scartozzi M, Tommasi C, Solinas C. Denaro N, et al. Semin Oncol. 2022 Dec;49(6):429-438. doi: 10.1053/j.seminoncol.2023.01.004. Epub 2023 Jan 27. Semin Oncol. 2022. PMID: 36737303 Review.

2

Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer.

Orlandi E, Miceli R, Infante G, Mirabile A, Alterio D, Cossu Rocca M, Denaro N, Vigna-Taglianti R, Merlotti A, Schindler A, Pizzorni N, Fallai C, Licitra L, Bossi P. Orlandi E, et al. Among authors: denaro n. Dysphagia. 2019 Feb;34(1):52-62. doi: 10.1007/s00455-018-9913-8. Epub 2018 Jun 8. Dysphagia. 2019. PMID: 29948260 Free article.

3

Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions.

Economopoulou P, Pantazopoulos A, Spathis A, Kotsantis I, Kyriazoglou A, Kavourakis G, Zakopoulou R, Chatzidakis I, Anastasiou M, Prevezanou M, Resteghini C, Licitra L, Bergamini C, Colombo E, Caspani F, Denaro N, Vecchio S, Bonomo P, Cossu Rocca M, Bertolini F, Ferrari D, Psyrri A, Bossi P. Economopoulou P, et al. Among authors: denaro n. Cells. 2021 Dec 23;11(1):32. doi: 10.3390/cells11010032. Cells. 2021. PMID: 35011594 Free PMC article.

4

Gefitinib in lung cancer therapy: clinical results, predictive markers of response and future perspectives.

Adamo V, Franchina T, Adamo B, Denaro N, Gambadauro P, Chiofalo G, Scimone A, Caristi N, Russo A, Giordano A. Adamo V, et al. Among authors: denaro n. Cancer Biol Ther. 2009 Feb;8(3):206-12. doi: 10.4161/cbt.8.3.7465. Epub 2009 Feb 20. Cancer Biol Ther. 2009. PMID: 19182534 Review.

5

Postoperative therapy in head and neck cancer: state of the art, risk subset, prognosis and unsolved questions.

Denaro N, Russi EG, Adamo V, Colantonio I, Merlano MC. Denaro N, et al. Oncology. 2011;81(1):21-9. doi: 10.1159/000330818. Epub 2011 Sep 8. Oncology. 2011. PMID: 21912194 Review.

6

MDM2 309 polymorphism predicts outcome in platinum-treated locally advanced head and neck cancer.

Vivenza D, Gasco M, Monteverde M, Lattanzio L, Syed N, Colantonio I, Denaro N, Natoli G, Comino A, Russi E, Merlano M, Crook T, Lo Nigro C. Vivenza D, et al. Among authors: denaro n. Oral Oncol. 2012 Jul;48(7):602-7. doi: 10.1016/j.oraloncology.2012.01.022. Epub 2012 Feb 21. Oral Oncol. 2012. PMID: 22356895

7

Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer.

Merlano MC, Monteverde M, Colantonio I, Denaro N, Lo Nigro C, Natoli G, Giurlanda F, Numico G, Russi E. Merlano MC, et al. Among authors: denaro n. Oral Oncol. 2012 Oct;48(10):1051-1057. doi: 10.1016/j.oraloncology.2012.05.001. Epub 2012 Jun 2. Oral Oncol. 2012. PMID: 22658677

8

The role of antiangiogenic agents in the treatment of head and neck cancer.

Denaro N, Russi EG, Colantonio I, Adamo V, Merlano MC. Denaro N, et al. Oncology. 2012;83(2):108-16. doi: 10.1159/000339542. Epub 2012 Jul 9. Oncology. 2012. PMID: 22777379 Review.

9

The role of neck dissection after radical chemoradiation for locally advanced head and neck cancer: should we move back?

Denaro N, Russi EG, Numico G, Pazzaia T, Vitiello R, Merlano MC. Denaro N, et al. Oncology. 2013;84(3):174-85. doi: 10.1159/000346132. Epub 2013 Jan 9. Oncology. 2013. PMID: 23306430 Review.

10

Strategies for non-resectable head and neck cancer.

Denaro N, Russi EG, Merlano MC. Denaro N, et al. Curr Treat Options Oncol. 2013 Dec;14(4):492-504. doi: 10.1007/s11864-013-0260-6. Curr Treat Options Oncol. 2013. PMID: 24065559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page